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Advances in Cell Line Engineering and
Protein Expression Strategies
Diane Hatton (MedImmune) and Steve Lang (Genentech)
Scope: Despite the wide use of CHO cells it has been a challenge to optimize
production of biologics beyond screening and upstream process improvements. This
paradigm is changing with the maturation of “omics” and gene editing techniques. The
industry is experiencing a renewed interest in pioneering efforts to better understand
CHO cells and engineer drug manufacturing productivity and quality. This workshop
will focus on sharing the latest concepts in automation in cell line development,
engineering for product quality and process performance as well as the strategies for
expressing novel protein formats. The discussion will span many topics including,
•
•
•
•
•

Current state of CHO genome sequences
Genome editing technologies
Engineered CHO cell lines, including contaminant-free CHO cell lines
Metabolism maps
Targeted integration

Advances in Cell Line Engineering and
Protein Expression Strategies
• Agenda:
– 20min opener and survey results
– 25min table discussion on selected topics
– 45min table read out and open discussion
• Students to help in discussions, taking notes

• Philosophy:
–
–
–
–
–

Work as table groups on different topics
Opportunity to interact with new people
Seek out different expertise and perspectives
Have plenty of time for discussion
Share outputs

Topics for tables
1.

Host cell line engineering

7.

Targeted/inducible expression

2.

"omics" technologies

3.

Transgene ‘mutation’ screening

8.

Automation & data management

4.

CLD for continuous processing

9.

New formats and non-traditional

5.

Synthetic biology CLD strategies

6.

Clonality for legacy cell lines

systems

therapies

10. Timeline acceleration
11. CHO alternatives and cell-free
systems

Potential discussion points to be distributed to tables.

Questions to discuss and read out
• Each table is listed with
a topic and potential
discussion points.
• Please select a
table/topic that you
would like to discuss.
• Discuss topics and
prepare a synopsis for
sharing with the entire
group.

• Additional questions if you
run out:
– What other pain points are
you experiencing?
– What are we missing in the
topic list?

• Suggestions for each table
– Roundtable introductions
– Define roles
• Scribe, Timekeeper, Presenter

Please rank the 3 topics of greatest interest to you
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** Most respondents selected more than 3 topics

Q30

Which of the above topics are you working on?
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** Most respondents selected more than 3 topics

Q31

In the next 5 years, what do you think will be the
biggest challenge for stable cell line development?

Q32

In the next 5 years, what could be disruptive
technologies for cell line and process development?

Q33

Teaser
• Share your challenges and learn from others
about advances in cell line engineering and
expression strategies. Win a prize for correctly
guessing the greatest challenge to cell line
development and the most anticipated
disruptive technology!

